drugset / Trial / NCT01655771
TD-1211 Single-Dose Study in Elderly and Young Healthy Subjects
Non-randomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to measure the way in which TD-1211 is absorbed and eliminated by the body and to evaluate whether it is safe and well tolerated.
Timeline
- Start
- 2012-08
- Primary completion
- 2013-02
- Completion
- 2013-03
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | axelopran | Small molecule | — | Oral |